PHARMACOTHERAPY FOR INFLAMMATORY DISEASES OF THE LUNG WITH DORNASEALPHA


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Mucolytics are extensively used in the treatment of various lung diseases with impaired mucociliary clearance and mucus hyperproduction. The role of recombinant human DNAase (rhDNAase, Pulmozyme) in the treatment of children and adults with lung disease not caused by cystic fibrosis has not been well established. The paper reviews the available reports on the results of clinical trials evaluating rhDNAase.

作者简介

T Gembitskaya

Email: mukoviscidoz otd@mail.ru

A Chermenskiy

Email: mukoviscidoz otd@mail.ru

T Gembitskaya

Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University

; Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University

A Chermensky

Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University

; Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University

参考

  1. Волков И.К. Возможности использования дорназы альфа (Пульмозим) в детской пульмонологии // Пульмонология. - 2004; 4: 113-117.
  2. Симанова Т.В., Ожегов A.M. Эффективность препарата Дорназа альфа у детей и подростков с хроническими воспалительными заболеваниями легких // Consilium medicum; 2008; приложение «Болезни органов дыхания»: 50-53.
  3. Berge M., Brinkhorst G., Kroon A.A., de Jongste J.С. Dnase treatment in primary ciliary dyskinesia - Assessment by nocturnal pulse oximetry // Pediatr. Pulmonol.-1999; 27: 59-61.
  4. Boeuf В., Prouix F., Morneau S. et al. Safety of endotracheal rhDNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children // Pediatr. Pulmonol. - 1998; 26:147.
  5. Boogaard R., Hulsmann A.R., van Veen L. et al. Recombinant human deoxyribonuclease in infants with respiratory syncytial virus bronchiolitis // Chest.-2007;131:788-795.
  6. Desai M.,Weller P.H..Spencer D.A. Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome // Pediatr. Pulmonol. - 1995; 20: 307-308.
  7. Durward A., Forte V., Shemie S.D. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus // Crit. Care Med. - 2000; 28: 560-562.
  8. Hendriks Т., de Hoog M., Lequin M.H. et al. DNase and atelectasis in non-cystic fibrosis pediatric patients // Crit. Care. - 2005; 9: 351-356.
  9. Kupeli S., Teksam O., Dogru D. et al. Use of recombinant human DNase in a premature infant with recurrent atelectasis // Pediatr. Int. -2003;45:584-586.
  10. Merkus P.J., de Hoog M., van Gent R. et al. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis // Eur. Respir. J.-2001; 18: 734-737.
  11. Nasr S.Z., Strouse P.J., Soskolne E. et al. Efficacy of recombinant human deoxyribonuclease lin the hospital management of respiratory syncytialvirus bronchiolitis // Chest. - 2001; 120: 203-208.
  12. Patel A., Harrison E., Durward A. et al. Intratracheal recombinant human deoxyribonuclease in acute life-threatening asthma refractory to conventional treatment// Br. J. Anaesth. - 2000; 84: 505-507.
  13. Reiter P.D., Townsend S.F., Velasquez R. Dornase alfa in premature infants with severe respiratory distress and early bronchopulmonary dysplasia //J. Perinatal. - 2000; 20: 530-534.
  14. Riethmueller J., Borth-Bruhns Т., Kumpf M. et al. Recombinant human deoxyribonuclease shortens ventilation time in young, mechanically ventilated children // Pediatr. Pulmonol. - 2006; 41: 61-66.
  15. Rogers D.F. Mucoactive drugs for asthma & COPD: any place in therapy? // Expert. Opin. Invest. Drugs. - 2002; 11:15-35.
  16. Simpson G., Roomes D., Reeves B. Succeful treatment of empyema thoracis with human recombinant deoxyribonuclease // Thorax. - 2003; 58: 363-366.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2022
##common.cookie##